Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.
Amazon S3 on MSN
The disturbing history of tuberculosis
While you don't hear much about it in the news today, Tuberculosis remains one of the deadliest diseases on the planet. More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results